American Renal Associates Holdings Inc. (NYSE:ARA) shares saw unusually-strong trading volume on Wednesday . Approximately 316,543 shares were traded during mid-day trading, an increase of 63% from the previous session’s volume of 194,771 shares.The stock last traded at $26.57 and had previously closed at $25.64.

A number of analysts have issued reports on ARA shares. Zacks Investment Research raised American Renal Associates Holdings from a “hold” rating to a “buy” rating and set a $29.00 price target on the stock in a research note on Monday. SunTrust Banks Inc. started coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “buy” rating and a $34.00 price target on the stock. Goldman Sachs Group Inc. started coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “neutral” rating and a $30.00 price target on the stock. Leerink Swann reissued an “outperform” rating on shares of American Renal Associates Holdings in a research note on Monday, May 16th. Finally, Wells Fargo & Co. started coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. American Renal Associates Holdings currently has an average rating of “Buy” and an average price target of $31.80.

The stock has a market cap of $590.36 million and a price-to-earnings ratio of 13.54. The firm’s 50-day moving average is $0.00 and its 200-day moving average is $0.00.

American Renal Associates Holdings (NYSE:ARA) last announced its quarterly earnings data on Thursday, May 12th. The company reported $0.16 earnings per share for the quarter. The firm earned $172.10 million during the quarter, compared to analyst estimates of $149.30 million. On average, equities research analysts anticipate that American Renal Associates Holdings Inc. will post $0.88 earnings per share for the current fiscal year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.